Why our customers prefer Blue Cross
- Option of getting insured without a medical exam
- Excellent rates
- Pioneer in the field of health insurance with over 80 years of experience
- Friendly service from experienced agents who can answer your questions and assist you when needed
- Coverage that can be customized to meet your specific needs
- Discounts and savings with our one-of-a-kind Blue Advantage program
Pharmacare in Canada: Is it time to explore the debate again?
Published on: October 1, 2015
Pharmacare has been a hotly debated topic for years in Canada. Is now the time to move forward with a universal health plan and provide Canadians with a publicly funded insurance plan for medications? Is it time to re-examine drug insurance plans and supplemental health insurance for RAMQ?
“Studies published in the Canadian Medical Association Journal, by the C.D. Howe Institute, the Institute for Research on Public Policy and the Canadian Federation of Nurses Unions have all come to essentially the same conclusion: Canada could save a whole whack of money if it replaced its current patchwork of private and public plans with a single national pharmacare plan,” says André Picard in the Globe and Mail. He continues: “Those estimated savings range from $4.2‑billion to $11.4‑billion on the annual prescription-drug bill, which currently sits at $29.3‑billion.”
It’s clear that rising prescription drug costs are making it more difficult for Canadians to pay for the medications they need. What health insurance covers is currently not enough. In Pharmacare 2020: The Future of Drug Coverage in Canada, the authors report that about one in 10 Canadians cannot afford their medications as prescribed by their doctors, and more than 9% of Canadians skip prescriptions because they can’t afford them.
How are Canadians currently paying for prescription drugs?
- 42% of drug costs are paid for by public drug programs
- 36% are paid for by private drug insurance plans
- 22% are paid out of pocket
“Most Canadians rely on private drug insurance but the most costly patients are on public plans,” says Picard.
The case for pharmacare
Today’s health care system consists of a combination of public and private drug insurance plans. These plans provide coverage to individuals based on where they live, their income and age, and where they work. Depending on where you work and on the details of your employee health insurance plan, certain medications may or may not be covered, or may be only partly covered. Individuals without health insurance, such the self-employed and those who work for companies without a group insurance plan, are forced to pay out of pocket for prescriptions, placing financial straits on many families.
Pharmacare would help standardize drug insurance plans. “It would provide equal access to prescription drugs for all Canadians, replacing our uneven patchwork of provincial programs and private insurance at work. It would also control costs by allowing providers to negotiate good prices and reducing administrative costs,” says the Canadian Health Coalition.
Some potential benefits of national pharmacare include:
- Equal access to prescription drugs
- Eliminated patchwork provincial programs, where access varies from person to person
- Reduced financial strain of prescription medications
- Peace of mind
- More effective control over drug costs
Potential issues with pharmacare in Canada
Those concerned that pharmacare is not the best option are concerned about:
- Tax implications
- Potential intervention by the federal government in a provincial jurisdiction
- Difficulty in determining which drugs should be included and excluded, and what criteria would be used
- Uncertain short- and long-term costs of implementation
- The impact a pharmacare program might have on drug costs and physicians’ prescribing practices
- The impact a pharmacare program might have on private health costs and private health insurance companies
- How the plan would be harmonized with current provincial drug plans
The proponents for mandatory drug insurance, which is the model used in Quebec, are finding that it could lead to issues in the future.
“The problem with Quebec’s approach, however, is that while it ensures universal drug coverage, it does not ensure equitable drug coverage. In fact, since Quebec adopted pharmacare in 1996, costs have soared because demand has soared, to the point where the provincial health ombudsman has warned that it is unsustainable. The Quebec experience is a sobering reminder that programs hailed as money-savers rarely turn out to be so,” says Picard.
Want to learn more about what health insurance can cover? Get a free health insurance quote for a Blue Cross drug insurance plan to help offset the costs of medications and treatments not covered by RAMQ.